Altimmune Sector: Dual GLP-1/glucagon receptor agonists for obesity and liver disease HQ: Gaithersburg, MD Year Founded: 1997 Origin Story: Altimmune originally focused on infectious disease vaccines and biodefense, including a formative all-stock merger with PharmAthene, a US biodefense drug specialist
It is interesting to note that the efficacy of Tirzepatide evaluated on a 7-point daily glucose profile demonstrated better control at all points of the glycemic profile compared to semaglutide 1 mg [3]
In this blog post, well dive into the latest findings from published phase 2 trials, explore retatrutides efficacy and safety, and look ahead to its future in phase 3 studies
It's alarming, but I try to focus on the positive changes in my health." " My doctor reassured me that the hair loss is temporary
Alex Azar, former Secretary of the US Department of Health and Human Services, noted that there is little stigma around taking a statin to manage high cholesterol, but using a GLP-1 to help with weight loss can be perceived by some as taking the easy way out. Panelists emphasized that this perception, despite its inaccuracy, persists and may stand in the way of patients accessing these effective treatments or staying on them long-term
The influence of GLP-1 analogs there can quickly spread throughout the brain, Skibicka says
